Physician profile
Eddy Sidra
NPI 1437792876
$2,875.57
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.89 · 2020: $864 · 2021: $1,446 · 2022: $24.26 · 2023: $211 · 2024: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $513.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $1,500.00 | 2020-2021 | |
| Alcon Vision LLC | $659.49 | 2020-2024 | Clareon |
| Coopervision INC. | $208.21 | 2020-2023 | Cvi Contact Lens |
| Carl Zeiss Meditec USA, INC. | $134.26 | 2024 | Cirrus Hd-Oct |
| Abbvie INC. | $111.50 | 2023 | Durysta |
| Biotissue Holdings INC. | $89.04 | 2024 | |
| Johnson & Johnson Vision Care, INC. | $71.55 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $48.00 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $42.74 | 2020-2021 | |
| Heidelberg Engineering, INC. | $10.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eddy Sidra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.